The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novartis' 2013 sales performance.
Novartis also hopes to help prevent future heart attacks or strokes through home-based digital solutions. ... Additionally, successful applicants will have access to the Novartis Biome UK system, alongside.
Through a collaboration and licence agreement with BeiGene, Novartis has the rights to develop, manufacture and commercialise tislelizumab in North America, Europe and Japan. ... combinations across additional tumour types that may benefit from an
Published: 04 May 2022. 1 Jul 2022. The National Institute for Health and Care Excellence (NICE) has issued a final draft recommendation for Novartis Pharmaceuticals UK’s Scemblix (asciminib) for patients
The National Institute for Health and Care Excellence (NICE) has issued a final draft recommendation for Novartis Pharmaceuticals UK’s Scemblix (asciminib) for patients with Philadelphia chromosome-positive chronic myeloid leukaemia ... Heather Moses,
Novartis and Precision BioSciences (Precision) have announced an in vivo gene editing research and development collaboration to develop potentially curative treatments for disorders including sickle cell disease (SCD) and beta thalassaemia.
PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...